Financial-Results (40)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE discontinues weekly 'Trade for Trade' (Series SZ) trading in Sahaj Fashions Limited effective April 15, 2026, following completion of … | |||||||||||||||
NSE discontinues weekly 'Trade for Trade' (Series SZ) trading in Sahaj Fashions Limited effective April 15, 2026, following completion of the mandated six-month weekly trading period for non-compliance with Regulation 33.
| |||||||||||||||
SEBI adjudication order imposing penalty on Nagarjuna Fertilizers and Chemicals Limited for violations of LODR Regulations including failure … | |||||||||||||||
SEBI adjudication order imposing penalty on Nagarjuna Fertilizers and Chemicals Limited for violations of LODR Regulations including failure to disclose arbitration award and financial results.
| |||||||||||||||
Insolation Energy Limited (BSE: 543620) announces board approval for unaudited financial results for H1 FY2026 and allotment of 51,625 … | |||||||||||||||
Insolation Energy Limited (BSE: 543620) announces board approval for unaudited financial results for H1 FY2026 and allotment of 51,625 equity shares under ESOP 2024, in connection with its migration from BSE SME to BSE Mainboard.
| |||||||||||||||
Insolation Energy Limited (BSE: 543620) is migrating its equity shares from the BSE SME Platform to the BSE Mainboard Platform. The company … | |||||||||||||||
Insolation Energy Limited (BSE: 543620) is migrating its equity shares from the BSE SME Platform to the BSE Mainboard Platform. The company also disclosed board meeting outcomes including unaudited financial results for H1 FY2026 and allotment of 51,625 equity shares under ESOP 2024.
| |||||||||||||||
Insolation Energy Limited's equity shares are migrating from the BSE SME Platform to the BSE Mainboard Platform. The company also disclosed … | |||||||||||||||
Insolation Energy Limited's equity shares are migrating from the BSE SME Platform to the BSE Mainboard Platform. The company also disclosed board meeting outcomes including approval of unaudited financial results for H1 FY2025-26 and allotment of 51,625 equity shares under ESOP 2024.
| |||||||||||||||
BSE announces suspension of trading in five companies effective March 13, 2026, for failure to comply with Regulation 33 requirements for … | |||||||||||||||
BSE announces suspension of trading in five companies effective March 13, 2026, for failure to comply with Regulation 33 requirements for two consecutive quarters (June 2025 and September 2025).
| |||||||||||||||
24 companies identified as non-compliant with financial results submission requirements will continue trading in Z Category (BZ/SZ Series) … | |||||||||||||||
24 companies identified as non-compliant with financial results submission requirements will continue trading in Z Category (BZ/SZ Series) on trade-for-trade basis effective January 27, 2026.
| |||||||||||||||
BSE to shift three companies to 'Z' group effective January 27, 2026 for failing to comply with quarterly financial results submission … | |||||||||||||||
BSE to shift three companies to 'Z' group effective January 27, 2026 for failing to comply with quarterly financial results submission requirements for June 2025 and September 2025 quarters.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, prepared as part … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, prepared as part of the company's migration from BSE SME to Mainboard platform.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, in connection with … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, in connection with migration from SME to Mainboard platform.
| |||||||||||||||